NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Chronicle Bio

Chronicle Bio

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://chroniclebio.com/

Last Round

Seed Round

Jul 7, 2026

Total Funding Raised

$5.36M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Chronicle Bio is a biotechnology company that has developed a data-driven healthcare platform designed to accelerate drug discovery for neuroimmune conditions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

AI drug discoverydrug discovery platformbiology foundation modelneuroimmune disorderspatient stratificationbiomarker discoverymulti-omic dataprecision medicinegenerative biologyLong COVIDME/CFSbiobankAI-ready datacomplex chronic diseasesdecentralized clinical trialsLarge Biological ModelsPOTS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chronicle Bio Comps

Public and private peers based on sector, stage, and business model.

Chronicle Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Chronicle Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 7, 2026
SeedJan 1, 2026

Chronicle Bio Investors

Notable investors and investment history

Chronicle Bio investors
InvestorRounds
Wisdom VenturesSeed
Electric CapitalSeed
Tarsadia InvestmentsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2026

    Raised $10.3M in a seed funding round.

  • Jan 1, 2026

    $5.36M round led by Tarsadia Investments and Electric Capital.

Chronicle Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Chronicle Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chronicle Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2025
Last FundingJul 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.